Trial intelligence / Profile preview

Gabapentin for acute renal colic pain control

IRCT20200322046833N2Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of gabapentin in Renal colic (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Time to pain control, Pain at discharge and 1 more. Started May 2021; status: completed.

02

Drugs

gabapentin
03

Conditions

Renal colic

Beyond the preview

Go deeper on IRCT20200322046833N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200322046833N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call